Clementia Pharmaceuticals Raises $120M In Upsized IPO
Clementia Pharmaceuticals Inc., a venture-backed Canadian drugmaker developing treatments for rare bone diseases, on Wednesday raised $120 million in an enlarged initial public offering that jumped in debut trading, under legal...To view the full article, register now.
Already a subscriber? Click here to view full article